What is the current Vaccines Delivery market size?

The Vaccines Delivery market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Vaccines Delivery market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Vaccines Delivery market?

Key drivers include rising vaccine demand, technological advancements, and government initiatives.

What challenges does the Vaccines Delivery market face?

Challenges include cold chain infrastructure, vaccine storage, and distribution logistics.

Which regions are leading the Vaccines Delivery market?

North America and Europe are regional leaders, with Asia Pacific emerging as a key market.

Who are the top companies in the Vaccines Delivery market?

Top companies include Pfizer, Merck, and GlaxoSmithKline, with emerging players in the market.

What future opportunities exist in the Vaccines Delivery market?

Future opportunities include innovative vaccine technologies and expanding vaccine access to emerging markets.

How is technology impacting the Vaccines Delivery market?

Technology is improving vaccine distribution, monitoring, and storage, enhancing the future outlook.

What is the current regulatory landscape for the Vaccines Delivery market?

The regulatory landscape is evolving, with a focus on vaccine safety, efficacy, and distribution regulations.

How will the Vaccines Delivery market size change in the next 5 years?

The market size is expected to increase significantly, driven by growing demand and advancements.

Vaccines Delivery Market Outlook, Trends & Forecast 2033

Vaccines Delivery by Application (Hospital, Clinic, Research Center), by Types (Biological Vector, Chemical Carrier, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Vaccines Delivery Market Size | CAGR 7.2 Forecast 2033

Vaccines Delivery Market Outlook, Trends & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Vaccines Delivery Market Overview

The Vaccines Delivery market refers to the industry involved in the development and distribution of vaccines to prevent and treat various diseases. As a critical component of global healthcare, the Vaccines Delivery market size is estimated to be around $43.8 billion in 2025. The growth outlook for this market is promising, with a projected market forecast of $64.3 billion by 2033, driven by increasing demand for vaccines and advancements in vaccine technology. The industry expansion is expected to be driven by key factors such as rising healthcare expenditure, growing awareness about vaccination, and government initiatives to improve vaccination coverage. The scope of this market encompasses various types of vaccines, including inactivated, live attenuated, and conjugate vaccines, as well as different applications, such as pediatric, adult, and travel vaccines.

Loading chart…

The Vaccines Delivery market is expected to grow at a CAGR of 7.5% from 2026 to 2033, driven by macro drivers such as increasing healthcare expenditure, growing demand for vaccines, and advancements in vaccine technology. Key forces shaping the industry include technology shifts towards more effective and efficient vaccine delivery systems, regulations and guidelines set by government agencies, and consumer behavior driven by growing awareness about vaccination. The largest region in the Vaccines Delivery market is North America, while the fastest-growing region is Asia-Pacific, driven by increasing demand for vaccines and growing healthcare infrastructure. Overall, the Vaccines Delivery market is expected to experience significant growth in the coming years, driven by increasing demand for vaccines and advancements in vaccine technology.

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	22.32 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Becton Dickinson and Company (BD); BioCSL; Novavax Inc.; Vaxart Inc.; Vaxxas; Echo Therapeutics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Vaccines Delivery market is witnessing significant transformations, driven by various factors that are reshaping its landscape. Understanding these dynamics is crucial for stakeholders to navigate the market effectively and capitalize on emerging opportunities.

Growth Drivers2 items

Advancements in vaccine technology and the development of novel vaccines are driving the Vaccines Delivery market size, with a growth forecast indicating a significant expansion in the coming years. This is attributed to increased investment in research and development by pharmaceutical companies and governments.

The rising prevalence of infectious diseases and the need for immunization programs are boosting demand for vaccines, thereby contributing to the growth of the Vaccines Delivery market. This trend is further exacerbated by global health initiatives and public-private partnerships aimed at improving access to vaccines.

Restraints2 items

Stringent regulatory requirements and the complex process of vaccine approval can hinder the Vaccines Delivery market growth, as companies must adhere to strict guidelines and face potential delays in bringing new vaccines to market.

The high cost associated with vaccine development and distribution, particularly in resource-poor settings, poses a significant restraint on the Vaccines Delivery market size, limiting access to vaccines in certain regions and demographics.

Opportunities2 items

The integration of cold chain technology in vaccine delivery systems presents a substantial opportunity for the Vaccines Delivery market, enabling the safe and efficient transportation of vaccines to remote and underserved areas.

Partnerships between vaccine manufacturers, governments, and non-governmental organizations (NGOs) can facilitate the expansion of the Vaccines Delivery market, enhancing vaccine coverage and accessibility worldwide.

Challenges2 items

The Vaccines Delivery market faces challenges related to supply chain disruptions, which can impact the availability and distribution of vaccines, particularly during public health emergencies.

Addressing vaccine hesitancy and misinformation about vaccines is a critical challenge for the Vaccines Delivery market, as it can affect demand and the overall effectiveness of vaccination programs.

Market Segmentation

Loading chart…

The Vaccines Delivery market can be segmented based on Application, which includes Influenza, Hepatitis, and Human Papillomavirus (HPV) among others. This segmentation contributes to the overall market size by providing insights into the specific disease areas where vaccines are being delivered, allowing for a more targeted approach to vaccine development and distribution. Understanding the Vaccines Delivery segmentation is crucial for industry players to identify areas of growth and opportunity.

Another key segmentation category in the Vaccines Delivery market is Types, which includes subtypes such as Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, and Conjugate Vaccines. Each subtype has its own unique characteristics, advantages, and applications, contributing to the overall market size. Analyzing these subtypes is essential for understanding the market taxonomy and identifying trends and patterns in the Vaccines Delivery market.

Vaccines Delivery Segmentation Breakdown8 items

Application

Hospital

Clinic

Research Center

Types

Biological Vector

Chemical Carrier

Others

Regional Insights

Loading chart…

The Vaccines Delivery market growth is anticipated to be driven by various regional factors. North America is the largest region, accounting for approximately 35% of the market, driven by high adoption rates, favorable policies, and significant investments in healthcare infrastructure. Key drivers for North America include a mature ecosystem, high demographics awareness, and advanced infrastructure.

Asia Pacific is the fastest-growing region, with a regional forecast indicating a significant increase in market share. This growth can be attributed to factors such as large demographics, increasing adoption of vaccines, and improving infrastructure. Europe, on the other hand, is driven by factors like favorable policies, high ecosystem maturity, and significant investments in research and development. Latin America and Middle East & Africa are also expected to contribute to the Vaccines Delivery market growth, driven by increasing adoption rates and improving infrastructure.

Key Regional Drivers5 items

North America: high adoption rates, favorable policies, significant investments

Asia Pacific: large demographics, increasing adoption, improving infrastructure

Europe: favorable policies, high ecosystem maturity, significant investments

Latin America: increasing adoption rates, improving infrastructure

Middle East & Africa: increasing adoption rates, improving infrastructure

Competitive Landscape

The Vaccines Delivery market is moderately consolidated, with a mix of global players and local companies competing on various fronts, including pricing, distribution, product innovation, certifications, and regulatory approvals. The Vaccines Delivery competitive landscape is characterized by high competition, with companies relying on key competitive levers such as product differentiation, channel strength, and cost advantages to gain market share.

Companies in the Vaccines Delivery market employ various strategies to differentiate themselves, including partnerships, product launches, and expansion into new regions. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To stay competitive, companies focus on technology, service model, and channel strength to differentiate themselves. The following companies have adopted distinct strategies:

Becton Dickinson and Company (BD) focuses on regional expansion

BioCSL prioritizes innovation pipeline

Novavax Inc. emphasizes vertical integration

Vaxart Inc. pursues OEM tie-ups

Vaxxas concentrates on local manufacturing

Echo Therapeutics explores premium pricing

Key Vaccines Delivery Companies6 items

Becton Dickinson and Company (BD)

BioCSL

Novavax Inc.

Vaxart Inc.

Vaxxas

Echo Therapeutics

Market Ecosystem

The Vaccines Delivery ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of vaccine delivery systems, with various stakeholders influencing the flow of goods, services, and information. The ecosystem's boundaries are defined by the interactions among these stakeholders, from raw material suppliers to end users, with each segment playing a distinct role in the value chain analysis.

Raw material suppliers — providing vaccine components

OEMs / manufacturers — producing vaccine delivery devices

System integrators / EPCs — integrating delivery systems

Distributors / channel partners — delivering products to end users

Service providers / after-sales — offering maintenance and support

Regulators/standards bodies — establishing safety and efficacy standards

End users / buyers — administering vaccines to patients

In the Vaccines Delivery ecosystem, control points are largely influenced by regulators and standards bodies, who set the criteria for safety and efficacy. Dependency risks arise from input constraints, such as the availability of raw materials, and standards approvals, which can impact the production and distribution of vaccine delivery systems. Switching costs and partnerships between stakeholders can also affect the ecosystem's dynamics, with some regions having distinct requirements and regulations. As a result, the Vaccines Delivery ecosystem differs by region, with varying levels of complexity and interoperability requirements.

Recent Industry Insights

The Vaccines Delivery industry has witnessed significant developments over the last 12-18 months, shaping the future of Vaccines Delivery industry trends. Notable partnerships have been formed between pharmaceutical companies and technology firms to enhance vaccine distribution and administration. Recent mergers and acquisitions have also led to the expansion of vaccine manufacturing capabilities, increasing the global supply of vaccines.

Furthermore, there have been several product launches and technology advancements in the field of vaccine delivery, including the development of more efficient and effective vaccine administration systems. Regulatory changes have also played a crucial role in shaping the industry, with governments implementing policies to improve vaccine accessibility and affordability. These developments have contributed to a shift in consumer and enterprise trends, with a growing focus on preventative healthcare and immunization.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Vaccines Delivery market. The market attractiveness is high due to increasing demand for effective vaccination programs. The competitive intensity is moderate, with key players focusing on innovation and partnerships. The long-term outlook for the Vaccines Delivery market outlook is positive, driven by advancements in technology and growing awareness about vaccine-preventable diseases.

The innovation landscape is dynamic, with ongoing research and development in areas like needle-free injections and personalized vaccines. However, the demand–supply balance is a key concern, with potential risks including shortages of critical vaccines and inequitable distribution. Key risk factors include regulatory changes, supply chain disruptions, and public perception of vaccine safety.

11 items

1. Executive Summary

2. Vaccines Delivery Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Vaccines Delivery Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Vaccines Delivery Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Research Center

6.2. Global Vaccines Delivery Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Biological Vector

6.2.2. Chemical Carrier

6.2.3. Others

6.3. Global Vaccines Delivery Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Vaccines Delivery Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Vaccines Delivery Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Vaccines Delivery Market Competition by Key Manufacturers

8.1. Global Vaccines Delivery Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Vaccines Delivery: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Becton Dickinson and Company (BD)

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. BioCSL

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Novavax Inc.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Vaxart Inc.

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Vaxxas

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Echo Therapeutics

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Vaccines Delivery Market

Figure 4: Global Vaccines Delivery Market: Drivers

Figure 5: Global Vaccines Delivery Market: Challenges

Figure 6: Global Vaccines Delivery Market: Trends

Figure 7: Global Vaccines Delivery Market: Opportunity

Figure 8: Global Vaccines Delivery Market: Restraint

Figure 9: Global Vaccines Delivery Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Vaccines Delivery Market Value (USD Million) By Region

Figure 15: Global Vaccines Delivery Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Vaccines Delivery Market Value (USD Million) By Region

Figure 23: Global Vaccines Delivery Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

65 items

Table 1: Market Segmentation Analysis

Table 2: Global Vaccines Delivery Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Vaccines Delivery Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Vaccines Delivery Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Vaccines Delivery Market Value (USD Million) By Region

Table 10: Global Vaccines Delivery Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Vaccines Delivery Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Vaccines Delivery Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Vaccines Delivery Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Becton Dickinson and Company (BD) Basic Information And Sales Area

Table 31: Becton Dickinson and Company (BD). Products Portfolio

Table 32: BioCSL Basic Information And Sales Area

Table 33: BioCSL. Products Portfolio

Table 34: Novavax Inc. Basic Information And Sales Area

Table 35: Novavax Inc.. Products Portfolio

Table 36: Vaxart Inc. Basic Information And Sales Area

Table 37: Vaxart Inc.. Products Portfolio

Table 38: Vaxxas Basic Information And Sales Area

Table 39: Vaxxas. Products Portfolio

Table 40: Echo Therapeutics Basic Information And Sales Area

Table 41: Echo Therapeutics. Products Portfolio

Table 42: Global Market Value (USD Million) (2025-2032) By Application

Table 43: Global Market Share (%) By Application (2032)

Table 44: Global Market Value (USD Million) (2025-2032) By Types

Table 45: Global Market Share (%) By Types (2032)

Table 46: Global Vaccines Delivery Market Value (USD Million) By Region

Table 47: Global Vaccines Delivery Market Share (%) By Region (2025-2032)

Table 48: North America Market Value (USD Million) (2025-2032) By Country

Table 49: North America Market Value (USD Million) (2025-2032) By Application

Table 50: North America Market Value (USD Million) (2025-2032) By Types

Table 51: Europe Market Value (USD Million) (2025-2032) By Country

Table 52: Europe Market Value (USD Million) (2025-2032) By Application

Table 53: Europe Market Value (USD Million) (2025-2032) By Types

Table 54: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 55: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 57: South America Market Value (USD Million) (2025-2032) By Country

Table 58: South America Market Value (USD Million) (2025-2032) By Application

Table 59: South America Market Value (USD Million) (2025-2032) By Types

Table 60: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 61: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 63: Research Programs/Design For This Report

Table 64: Key Data Information From Secondary Sources

Table 65: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Vaccines Delivery Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	22.32 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Becton Dickinson and Company (BD); BioCSL; Novavax Inc.; Vaxart Inc.; Vaxxas; Echo Therapeutics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options